These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
498 related articles for article (PubMed ID: 28371822)
1. ELABELA-APJ axis protects from pressure overload heart failure and angiotensin II-induced cardiac damage. Sato T; Sato C; Kadowaki A; Watanabe H; Ho L; Ishida J; Yamaguchi T; Kimura A; Fukamizu A; Penninger JM; Reversade B; Ito H; Imai Y; Kuba K Cardiovasc Res; 2017 Jun; 113(7):760-769. PubMed ID: 28371822 [TBL] [Abstract][Full Text] [Related]
2. Apelin and Elabela/Toddler; double ligands for APJ/Apelin receptor in heart development, physiology, and pathology. Kuba K; Sato T; Imai Y; Yamaguchi T Peptides; 2019 Jan; 111():62-70. PubMed ID: 29684595 [TBL] [Abstract][Full Text] [Related]
3. Loss of Apelin Augments Angiotensin II-Induced Cardiac Dysfunction and Pathological Remodeling. Sato T; Kadowaki A; Suzuki T; Ito H; Watanabe H; Imai Y; Kuba K Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30634441 [TBL] [Abstract][Full Text] [Related]
4. The Elabela-APJ axis: a promising therapeutic target for heart failure. Ma Z; Song JJ; Martin S; Yang XC; Zhong JC Heart Fail Rev; 2021 Sep; 26(5):1249-1258. PubMed ID: 32314083 [TBL] [Abstract][Full Text] [Related]
5. ELABELA antagonizes intrarenal renin-angiotensin system to lower blood pressure and protects against renal injury. Xu C; Wang F; Chen Y; Xie S; Sng D; Reversade B; Yang T Am J Physiol Renal Physiol; 2020 May; 318(5):F1122-F1135. PubMed ID: 32174138 [TBL] [Abstract][Full Text] [Related]
6. Osteopontin RNA aptamer can prevent and reverse pressure overload-induced heart failure. Li J; Yousefi K; Ding W; Singh J; Shehadeh LA Cardiovasc Res; 2017 May; 113(6):633-643. PubMed ID: 28453726 [TBL] [Abstract][Full Text] [Related]
7. Apelin is a positive regulator of ACE2 in failing hearts. Sato T; Suzuki T; Watanabe H; Kadowaki A; Fukamizu A; Liu PP; Kimura A; Ito H; Penninger JM; Imai Y; Kuba K J Clin Invest; 2013 Dec; 123(12):5203-11. PubMed ID: 24177423 [TBL] [Abstract][Full Text] [Related]
8. Pathological Ace2-to-Ace enzyme switch in the stressed heart is transcriptionally controlled by the endothelial Brg1-FoxM1 complex. Yang J; Feng X; Zhou Q; Cheng W; Shang C; Han P; Lin CH; Chen HS; Quertermous T; Chang CP Proc Natl Acad Sci U S A; 2016 Sep; 113(38):E5628-35. PubMed ID: 27601681 [TBL] [Abstract][Full Text] [Related]
9. Apelin and APJ orchestrate complex tissue-specific control of cardiomyocyte hypertrophy and contractility in the hypertrophy-heart failure transition. Parikh VN; Liu J; Shang C; Woods C; Chang AC; Zhao M; Charo DN; Grunwald Z; Huang Y; Seo K; Tsao PS; Bernstein D; Ruiz-Lozano P; Quertermous T; Ashley EA Am J Physiol Heart Circ Physiol; 2018 Aug; 315(2):H348-H356. PubMed ID: 29775410 [TBL] [Abstract][Full Text] [Related]
10. Therapeutic potential of apelin and Elabela in cardiovascular disease. Gao S; Chen H Biomed Pharmacother; 2023 Oct; 166():115268. PubMed ID: 37562237 [TBL] [Abstract][Full Text] [Related]
11. Elabela/Toddler Is an Endogenous Agonist of the Apelin APJ Receptor in the Adult Cardiovascular System, and Exogenous Administration of the Peptide Compensates for the Downregulation of Its Expression in Pulmonary Arterial Hypertension. Yang P; Read C; Kuc RE; Buonincontri G; Southwood M; Torella R; Upton PD; Crosby A; Sawiak SJ; Carpenter TA; Glen RC; Morrell NW; Maguire JJ; Davenport AP Circulation; 2017 Mar; 135(12):1160-1173. PubMed ID: 28137936 [TBL] [Abstract][Full Text] [Related]
12. Gαi-biased apelin analog protects against isoproterenol-induced myocardial dysfunction in rats. Coquerel D; Delile E; Dumont L; Chagnon F; Murza A; Sainsily X; Salvail D; Sarret P; Marsault E; Auger-Messier M; Lesur O Am J Physiol Heart Circ Physiol; 2021 Apr; 320(4):H1646-H1656. PubMed ID: 33635165 [TBL] [Abstract][Full Text] [Related]
14. Disruption of actin dynamics regulated by Rho effector mDia1 attenuates pressure overload-induced cardiac hypertrophic responses and exacerbates dysfunction. Abe I; Terabayashi T; Hanada K; Kondo H; Teshima Y; Ishii Y; Miyoshi M; Kira S; Saito S; Tsuchimochi H; Shirai M; Yufu K; Arakane M; Daa T; Thumkeo D; Narumiya S; Takahashi N; Ishizaki T Cardiovasc Res; 2021 Mar; 117(4):1103-1117. PubMed ID: 32647865 [TBL] [Abstract][Full Text] [Related]
15. Cardioprotective effects of granulocyte colony-stimulating factor in angiotensin II-induced cardiac remodelling. Jia N; Dong P; Huang Q; Jin W; Zhang J; Dai Q; Liu S Clin Exp Pharmacol Physiol; 2009 Mar; 36(3):262-6. PubMed ID: 18785976 [TBL] [Abstract][Full Text] [Related]
16. ELABELA improves endothelial cell function via the ELA-APJ axis by activating the PI3K/Akt signalling pathway in HUVECs and EA.hy926 cells. Wang X; Liang G; Guo Q; Cai W; Zhang X; Ni J; Tao Y; Niu X; Chen S Clin Exp Pharmacol Physiol; 2020 Dec; 47(12):1953-1964. PubMed ID: 32687618 [TBL] [Abstract][Full Text] [Related]
17. Endothelial deletion of protein tyrosine phosphatase-1B protects against pressure overload-induced heart failure in mice. Gogiraju R; Schroeter MR; Bochenek ML; Hubert A; Münzel T; Hasenfuss G; Schäfer K Cardiovasc Res; 2016 Aug; 111(3):204-16. PubMed ID: 27207947 [TBL] [Abstract][Full Text] [Related]